WX
WuXi Biologics (Cayman) Inc.
WXIBF · OTC
$6.23 +0.00% (+$0.00)
1M +6.50%
Market Cap ¥172.8B
P/E Ratio 36.14x
Div. Yield -
ROE 10.50%
Bulios Fair Price
$4.91
21.1% downside
Trenutna cena
$6.23
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica WXIBF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
9/9Valuation
24 /100
Expensive PEG 0.85x
P/E 36.14x
P/B 3.66x
Growth
60 /100
Stable Book val. growth 10.49%
EPS growth 3.51%
Rev. growth 11.61%
Profitability
92 /100
Strong Op. margin 30.50%
Gross margin 45.98%
FCF margin 13.19%
Quality
49 /100
Average ROA 7.50%
ROIC 9.03%
Asset turnover 0.33x
Debt
100 /100
Low Int. coverage 46.46x
Debt/Equity 0.07x
Net debt/EBITDA -0.75x
Stability
88 /100
Stable EPS volatility 34.04%
Beta 0.60x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o WXIBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zhisheng Chen
Employees
13,252
Headquarters
Wuxi
Prihajajoči dogodki
23 MAR.
Earnings
Upcoming earnings report